Total current assets Total assets Total current liabilities Total liabilities Total shareholders’ equity Balance Balance Total liabilities and shareholders’ equity Total operating expenses Loss from operations Total other income, net Net loss Net loss Net losses Total other comprehensive income (loss): Comprehensive loss Balance (in Shares) Balance (in Shares) Equity Components [Axis] Net cash used in operating activities Cash for operating activities Net cash provided in financing activities Net increase (decrease) in cash, cash equivalents and restricted cash Cash, cash equivalents, and restricted cash, beginning of period Cash, cash equivalents, and restricted cash, end of period Total cash, cash equivalents, and restricted cash The Company and Basis of Presentation [Abstract] Consolidated Entities [Axis] Geographical [Axis] Summary of Significant Accounting Policies [Abstract] Long-Lived Tangible Asset [Axis] Fair Value Measurement [Abstract] Total liabilities measured at fair value Fair Value Hierarchy and NAV [Axis] Measurement Frequency [Axis] Financial Instrument [Axis] Balance at beginning Balance at ending Accounts Receivable, Non-trade [Abstract] Schedule of Accounts Receivable, Non-Trade [Abstract] Total accounts receivable, non-trade Accounts receivable, non-trade Property and Equipment, Net [Abstract] Property and equipment, net Property and equipment, net Leases [Abstract] Schedule of Operating and Finance Leases [Abstract] Total operating lease liability Present value of operating lease liability Schedule of Effect of Lease Costs in our Consolidated Statements of Operations and Comprehensive Loss [Abstract] Total Schedule of Lease Payments Through the end of the Expected Lease Term are Expected [Abstract] Total lease payments Goodwill [Abstract] Schedule of Carrying Value of Goodwill [Abstract] Carrying amount, Beginning Carrying amount, Ending Goodwill Intangible Assets [Abstract] Carrying amount, Balance Carrying amount, Balance Intangible assets, net Finite-Lived Intangible Assets by Major Class [Axis] Accrued Expenses and Other Current Liabilities [Abstract] Schedule of Accrued Expenses [Abstract] Total accrued expenses and other current liabilities Accrued expenses and other current liabilities Share Based Compensation [Abstract] Statistical Measurement [Axis] Number of Options, Outstanding Ending Balance Weighted Average Exercise Price per Share, Outstanding Ending Balance Aggregate Intrinsic Value, Outstanding Ending Balance Private Placement [Abstract] Measurement Input Type [Axis] Warrants [Abstract] Number of ADS Warrants, Opening balance at beginning of financial year Number of ADS Warrants, Closing balance at June 30 Weighted Average Exercise Price, Opening balance at beginning of financial year Weighted Average Exercise Price, Closing balance at June 30 Class of Warrant or Right [Axis] Income Taxes [Abstract] Schedule of Components of Loss Before Income Taxes [Abstract] Total Loss before income taxes Loss before taxes: Schedule of Components of Income Tax Benefit [Abstract] Total current Total deferred Total income tax benefit Income tax benefit Schedule of Reconciliation Between Income Tax Benefit and the Expected Tax Benefit [Abstract] Schedule of Deferred Tax Liabilities [Abstract] Total deferred tax assets Total deferred tax liability Net deferred tax liability Loss per Share [Abstract] Antidilutive Securities [Axis] Related Party Transactions [Abstract] Contingent Consideration [Abstract] Schedule of Change in Fair Value of the Contingent Consideration Liability [Abstract] Balance at beginning Balance at ending Contingent consideration Commitments and Contingencies [Abstract] Subsequent Events [Abstract] Assets Current assets: Cash and cash equivalents Prepaid insurance expense Operating lease right-of-use assets Restricted cash Liabilities and Shareholders’ Equity Current liabilities: Accounts payable Operating lease liability Operating lease liability, short-term Operating lease liability, net of current portion Operating lease liability, long-term Contingent consideration Deferred tax liability Accompanying warrants liability Warrant liability Other non-current liabilities Commitments and contingencies (Note 17) Shareholders’ equity: Ordinary shares, no par value; 2,384,539,964 and 1,468,735,424 shares issued and outstanding at June 30, 2024 and 2023, respectively Ordinary shares, no par value; 1,468,735,424 shares issued and outstanding at June 30, 2023 Ordinary shares, no par value (in Dollars per share) Ordinary shares, par value (in Dollars per share) Par value per share Ordinary shares, shares issued Ordinary shares, shares outstanding Additional paid in capital Additional paid-in capital Accumulated other comprehensive loss, net of tax Accumulated deficit Operating expenses: Research and development General and administrative Other income: Interest income, net (Loss) gain on foreign currency transactions Gain (loss) on fair value adjustments Other comprehensive (loss) income: Unrealized gain (loss) on foreign currency translation Net loss per share —basic (in Dollars per share) Net loss per share —diluted Weighted-average common shares outstanding—basic (in Shares) Weighted-average common shares outstanding—diluted Issuance of ADS shares and pre-funded ADS warrants Issuance of ADS shares and pre-funded ADS warrants (in Shares) Shares issued (in Shares) Net of issuance costs Net of Issuance Costs Share-based compensation Exercise of common stock options Cash flows from operating activities: Adjustments to reconcile net loss to net cash used in operating activities: Share-based compensation Depreciation and amortization expense Change in fair value of accompanying warrant liability Change in fair value of contingent consideration Change in fair value Changes in assets and liabilities: Accounts payable Accrued expenses and other current liabilities Operating lease liability Deferred tax liability Other non-current liabilities Cash flows from financing activities: Proceeds from sale of ADS shares and ADS pre-funded warrants Proceeds from sale of ADS shares Proceeds from the sale of accompanying ADS warrants Effect of exchange rate on changes on cash, cash equivalents, and restricted cash Reconciliation of cash, cash equivalents, and restricted cash at end of year: Restricted cash Supplemental cash flow data: Cash paid for interest expense Cash paid for income tax expense Research and development incentive award Other comprehensive income (loss) Non-cash rent expense Effect of foreign currency remeasurement Accounts receivable, non-trade Prepaid insurance expense Ordinary Shares Additional Paid-In Capital Accumulated Other Comprehensive Loss Accumulated Deficit The Company and Basis of Presentation Schedule of Company’s Entity Structure at the End of the Reporting Period Entity Country of Incorporation Schedule of Presentation Under IFRS and U.S. GAAP Shareholders’ equity: Issued Capital Reserves Shareholders’ equity: Summary of Significant Accounting Policies Schedule of Useful Lives of the Property and Equipment Estimated Useful Life Fair Value Measurement Schedule of Company’S Liabilities at Fair Value on a Recurring Basis Liabilities: Liabilities Liabilities: Schedule of Fair Value was Determined by Level 3 Inputs Schedule of Change in Fair Value of the Contingent Consideration Liability Change in fair value Issuance of freestanding financial instruments Accounts Receivable, Non-trade Schedule of Accounts Receivable, Non-Trade